TY - JOUR
T1 - Structure-function relationships among ryanodine derivatives. Pyridyl ryanodine definitively separates activation potency from high affinity
AU - Bidasee, Keshore R.
AU - Besch, Henry R.
N1 - Copyright:
Copyright 2007 Elsevier B.V., All rights reserved.
PY - 1998/5/15
Y1 - 1998/5/15
N2 - Ryanodine derivatives are differentially effective on the two limbs of the ryanodine concentration-effect curve. This study comparing ryanodine, ryanodol, and pyridyl ryanedine and nine C10O(eq) esters of them focuses on structure-function relations underlying their differential effectiveness. Ryanodol and pyridyl ryanodine had significantly lower affinities than ryanodine, but their EC(50act) values (concentration of ryanoid that induces one-half of full efficacy), potencies, and efficacies were not diminished in like fashion. Ryanodine and ryanodol were partial agonists, whereas pyridyl ryanodine was a full agonist, having a diminished deactivation potency. C10O(eq) esterifications enhanced affinities and efficacies of the base ryanoids. The C10-O(eq) ester derivatives of ryanodine and pyridyl ryanodine, but not those of ryanodol, lost their capacity to deactivate RyR1s. Thus, affinity differences among ryanoids clearly do not predicate functional differences as regards activation of Ca2+ release channels. The pyrrole carboxylate on the C3 of ryanodine is dispensable to ryanoid activation of Ca2+ release channels. Ryanodol lacks this ring, but it nevertheless effects substantial activation. Moreover, its C10-O(eq) esters display full efficacy. The increased ability of all the C10-O(eq) derivatives to release Ca2+ from the vesicles strengthens their role in directly impeding deactivation of RyR1, perhaps by interaction with some component within the transmembrane ionic flux pathway.
AB - Ryanodine derivatives are differentially effective on the two limbs of the ryanodine concentration-effect curve. This study comparing ryanodine, ryanodol, and pyridyl ryanedine and nine C10O(eq) esters of them focuses on structure-function relations underlying their differential effectiveness. Ryanodol and pyridyl ryanodine had significantly lower affinities than ryanodine, but their EC(50act) values (concentration of ryanoid that induces one-half of full efficacy), potencies, and efficacies were not diminished in like fashion. Ryanodine and ryanodol were partial agonists, whereas pyridyl ryanodine was a full agonist, having a diminished deactivation potency. C10O(eq) esterifications enhanced affinities and efficacies of the base ryanoids. The C10-O(eq) ester derivatives of ryanodine and pyridyl ryanodine, but not those of ryanodol, lost their capacity to deactivate RyR1s. Thus, affinity differences among ryanoids clearly do not predicate functional differences as regards activation of Ca2+ release channels. The pyrrole carboxylate on the C3 of ryanodine is dispensable to ryanoid activation of Ca2+ release channels. Ryanodol lacks this ring, but it nevertheless effects substantial activation. Moreover, its C10-O(eq) esters display full efficacy. The increased ability of all the C10-O(eq) derivatives to release Ca2+ from the vesicles strengthens their role in directly impeding deactivation of RyR1, perhaps by interaction with some component within the transmembrane ionic flux pathway.
UR - http://www.scopus.com/inward/record.url?scp=0032524882&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032524882&partnerID=8YFLogxK
U2 - 10.1074/jbc.273.20.12176
DO - 10.1074/jbc.273.20.12176
M3 - Article
C2 - 9575165
AN - SCOPUS:0032524882
VL - 273
SP - 12176
EP - 12186
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
SN - 0021-9258
IS - 20
ER -